Lansoprazol Davur

Lansoprazole, the active ingredient in Lansoprazol Davur, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of acid‑related disorders such as gastro‑esophageal reflux disease and peptic ulcer disease.

GNH USA supplies Lansoprazol Davur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric proton pump to lower acid secretion, making it useful for several acid‑related conditions. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of esophageal irritation. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens. - Zollinger‑Ellison syndrome: controls excessive gastric acid production.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, often transient. - Nausea: occasional feeling of queasiness. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe diarrhea with abdominal pain. - Elevated liver enzymes: signs of hepatic stress. - Hypomagnesemia: low magnesium levels causing muscle cramps. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder. - Interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use in patients with severe renal impairment. - Monitor for infection: prolonged therapy may increase risk of gastrointestinal infections. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Use cautiously in elderly: higher incidence of fractures and bone loss. - Store at room temperature: keep in the original container, protect from moisture and light.

Lansoprazole may affect the pharmacokinetics of several concomitant medicines.

Major Interactions (Avoid): - Ketoconazole: reduced absorption and efficacy of ketoconazole. - Clopidogrel: decreased antiplatelet effect, increasing cardiovascular risk. - Atazanavir: markedly decreased atazanavir exposure.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring closer monitoring. - Digoxin: possible rise in serum digoxin levels. - Methotrexate: may increase methotrexate toxicity, especially at high doses.